Products

BRCA MASTR Dx - Multiplicom

A CE-IVD validated diagnostic assay of breast and ovarian related cancer for the detection by NGS

BRCA MASTR™ Dx is a CE-IVD labeled molecular diagnostic assay for the identification of mutations in the coding regions of  BRCA1 and BRCA2 in individuals with increased risk for breast, ovarian and/or related cancers.

Mutations in BRCA1 and BRCA2 have been linked to the development of hereditary breast- and ovarian cancer. Female mutation carriers, for either gene, have 60 % to 80 % lifetime risk of developing breast cancer and 20 % to 50 % of developing ovarian cancer. Male BRCA2 carriers have 6 % to 8 % lifetime risk of developing pancreatic, hepatic, prostate and breast cancer and can pass the mutation on to their children. 

Family history and age are the most important criteria for a genetic testing request. Upon detection of a mutation various mitigation options are available to reduce the chance of developing cancer and the overall mortality rate. These options include preventive double mastectomy, as was famously chosen by Angelina Jolie in 2013, hormone replacement therapy, chemoprevention strategies and prophylactic measures. 

Given the effective preventive measures that are available, screening for mutations in the BRCA gene enables healthcare providers and patients the information to make well-informed decisions. The BRCA MASTR Dx is the market-leading solution on which clinical geneticist and patients rely.

Show more

http://www.multiplicom.com/product/brca-mastr-dx
Petra Kupková

Sales manager

Petra

Kupková

+420 731 426 051

Send Message

Related products

These kits are to be used for the second PCR step to incorporate barcoding and adaptors required for 454 GS Junior or 454 GS FLX instruments (Roche).

show detail

A homopolymer assay for MASTR™ assays to allow rapid detection of small insertion/deletion mutations in the coding homopolymer stretches of the targeted genes.

show detail

The BRCA MAQ assay is intended for CNV detection in the BRCA1 and BRCA2 genes.

show detail

These kits are to be used in combination with the MASTR™ assays.

show detail

The kits are to be used in combination with the MASTR™ assays for the second PCR to incorporate barcoding and adaptors required for the Ion PGM™ System.

show detail

This assay is to be used in combination with the MASTR assays, for applications on

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey